New evidence
A systematic review finds riboflavin tied to functional improvements after stroke and birth-related oxygen deprivation — but not for multiple sclerosis, narrowing the potential benefit.
This is among the first indexed reviews on riboflavin for neurological disorders, so the finding is novel but preliminary: the apparent benefit for stroke and perinatal asphyxia rests on small studies and needs replication before it changes practice.
A systematic review of riboflavin (vitamin B2) for neurological conditions found clinical evidence that it may help regulate oxidative stress and improve functional outcomes after stroke and perinatal asphyxia. However, the same review tested riboflavin against several other neurological outcomes — including demyelinating diseases like multiple sclerosis — and saw no effect. With the overall evidence still sparse, the result is promising but far from conclusive.
Where this fits in the evidence
This is among the first studies we've indexed on Vitamin B2 for Improved Functional Outcome — treat it as an early signal until more research accumulates.
The study
- Systematic Review
- 2026-07
- The Journal of nutrition
This is a plain-language summary of a research finding, not medical advice. Pillser surfaces research signals to help you decide what's worth investigating — always consult a qualified professional before changing what you take.